As of 2026-04-07, the Relative Valuation of G1 Therapeutics Inc (GTHX) is (17.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.15 USD, the upside of G1 Therapeutics Inc based on Relative Valuation is -345.1%.
The range of the Relative Valuation is (16.04) - (18.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 22.5x | 20.4x |
| Forward P/E multiples | 18.1x - 21.3x | 20.9x |
| Fair Price | (16.04) - (18.04) | (17.52) |
| Upside | -324.3% - -352.3% | -345.1% |
| Date | P/E |